ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

ARRA Funding Announcements Listed

April 10, 2009

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

Lung cancer screening trial reaches accrual goal of 50,000.

January 30, 2004